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Abstract: Prion proteins (PrP) of mammals, birds, reptiles and amphibians have been successfully cloned,
expressed and purified in sufficient yields to enable 3D structure determination by NMR spectroscopy
in solution. More recently, PrP ortholog genes have also been identified in several fish species, based on
sequence relationships with tetrapod PrPs. Even though the sequence homology of fish PrPs to tetrapod
PrPs is below 25%, structure prediction programs indicate a similar organization of the 3D structure. In
this study, we generated recombinant polypeptide constructs that were expected to include the C‐terminal
folded domain of Fugu‐PrP1 and analyzed these proteins using biochemical and biophysical methods.
Because soluble expression could not be achieved, and refolding from guanidine–HCl did not result in a
properly folded protein, we co‐expressed Escherichia coli chaperone proteins in order to obtain the protein
in a soluble form. Although CD spectroscopy indicated the presence of some regular secondary structure
in the protein thus obtained, there was no evidence for a globular 3D fold in the NMR spectra. We thus
conclude that the polypeptide products of the fish genes annotated as corresponding to bona fide prnp
genes in non‐fish species cannot be prepared for structural studies when using procedures similar to those
that were successfully used with PrPs from mammals, birds, reptiles and amphibians.
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Abbreviations: GPI, glycosylphosphatidylinositol; HSQC, heteronuclear single quantum 
coherence; IPTG, isopropyl-β-D-1-thiogalactopyranoside; PrP, prion protein; tr1-PrP, 6 x 
His-tagged Fugu-PrP1(298−423); mPrP, mouse prion protein; hPrP, human prion protein; 
SH3, Src homology domain 3; TSE, transmissible spongiform encephalopathy. 
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Summary 
Prion proteins (PrP) of mammals, birds, reptiles and amphibians have been successfully 
cloned, expressed and purified in sufficient yields to enable three-dimensional structure 
determination by nuclear magnetic resonance spectroscopy in solution. More recently, PrP 
orthologue genes have also been identified in several fish species, based on sequence 
relationships with tetrapod PrPs. Even though the sequence homology of fish PrPs to 
tetrapod PrPs is below 25%, structure prediction programs indicate a similar organization 
of the three-dimensional structure. In this work, we generated recombinant polypeptide 
constructs that were expected to include the C-terminal folded domain of Fugu-PrP1 and 
analyzed these proteins with biochemical and biophysical methods. Since soluble 
expression could not be achieved, and refolding from guanidine-HCl did not result in a 
properly folded protein, we co-expressed E. coli chaperone proteins in order to obtain the 
protein in a soluble form. Although circular dichroism spectroscopy indicated the presence 
of some regular secondary structure in the protein thus obtained, there was no evidence 
for a globular three-dimensional fold in the NMR spectra. We thus had to conclude that the 
polypeptide products of the fish genes annotated as corresponding to bona fide prnp 
genes in non-fish species cannot be prepared for structural studies when using similar 
procedures to those that were successfully used with PrP from mammals, birds, reptiles 
and amphibians. Although the outcome of this study represents a negative result we 
consider this result in respect of our long lasting experience in recombinant prion protein 
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Introduction 
Prion diseases, such as scrapie in sheep, bovine spongiform encephalopathy (BSE), 
chronic wasting disease (CWD) in deer, and Creutzfeldt-Jakob disease (CJD) in humans, 
are related to the conversion of the cellular form of the prion protein (PrPC) to a protease-
resistant β-sheet-rich form (PrPSc) [1]. Prion proteins from mammals, birds, reptiles and 
amphibians all possess the same molecular architecture, consisting of a flexibly extended 
100-residue N-terminal tail and a globular C-terminal domain of similar size [2-7]. The C-
terminal globular domain is preceeded by a highly conserved hydrophobic polypeptide 
segment (figure 1). Its well-defined structure with three α-helices and an antiparallel β-
sheet could be identified in all species studied so far [7]. Posttranslational modifications 
such as cleavage of N- and C-terminal signal sequences during the import into the 
endoplasmatic reticulum, formation of a disulfide bond that connects the helices α2 and 
α3, N-linked glycosylation in two sites, and addition of a C-terminal GPI anchor are present 
in all these species, which also contain putative SH3- and laminin-α2-receptor binding 
sites [7, 8]. The physiological role in the healthy organisms and the evolutionary origin of 
PrPs remain controversial [9, 10]. 
Recently, genes coding for putative prion proteins in fish species such as Japanese 
pufferfish (Fugu rubripes) [11, 12], green spotted pufferfish (Tetraodon nigroviridis) [13], 
zebrafish (Danio rerio) [13, 14], atlantic salmon (Salmo salar) [12], rainbow trout 
(Onchorhynchus mykiss) [15], three-spine stickleback (Gasterosteus aculeatus) [8, 16], 
carp (Cyprinus carpio) [8], gilthead seabream (Sparus aurata) [17], Japanese medaka 
(Oryzias latipes) [GenBank: CAL64054], Japanese seabass (Lateolabrax japonicus) and 
Japanese flounder (Paralichthys olivaceus) [18] have been described and compared (for a 
sequence alignment, see Rivera-Milla et al. [8]). An early whole-genome duplication that 
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occurred in the evolution of ray-finned fish [19-23] resulted in the presence of two fish PrPs 
(PrP1 and PrP2), whereas only one PrP was identified in tetrapod species. 
Comparison of biophysical and structural properties of tetrapod PrPs with fish PrPs might 
help to improve our understanding of PrP biology, such as structure−function relationships 
in healthy organisms, and species barriers in TSEs. In addition, new insights into the 
evolutionary development of PrPs might be obtained.  
To begin of our work, we tried to express and purify the putative domains of Fugu 
(Takifugu rubripes) PrP2 (aa 215−404), Zebrafish (Danio rerio) PrP1 (aa 389−581) and 
PrP2 (aa 311−541) with the protocol used for other PrPs [4, 24].  However, we found that 
the proteins were only expressed at very low levels. We decided, therefore, to focus our 
work on the putative C-terminal domain of Takifugu rubripes PrP1, spanning residues 
298−423, which could be obtained in sufficient quantities and, thus, appeared to us as the 
most promising candidate for further studies. 
In a first approach, the protein was expressed in inclusion bodies followed by refolding 
attempts from guanidine-HCl by conventional Nickel-affinity chromatography. In a second 
approach, the protein was obtained in soluble oxidized form by co-expression with E. coli 
chaperone proteins [25-27] and purified without use of denaturants. The proteins thus 
obtained were studied with circular dichroism (CD) and nuclear magnetic resonance 
(NMR) spectroscopy. The results presented in this study show that the putative C-terminal 
domain of Takifugu rubripes PrP1 does not exhibit a defined three-dimensional fold.  
We are aware about the fact that we are reporting here a negative result. However, the 
finding that fish PrPs cannot be handled as other prion proteins appears to us as quite 
intriguing, especially in the light of our success and experience in expressing and purifying 
prion proteins from a wide variety of species. Regarding this aspect and that the 
 
 - 6 - 
expression and purification of fish PrPs was a long-standing experiment we feel that we 
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Results and discussion 
Identification of the putative C-terminal domain of Takifugu rubripes PrP1 
An alignment of Takifugu rubripes PrP1 and PrP2 with murine PrP is shown in Figure 1. 
We determined the polypeptide segment of Takifugu rubripes PrP1 that should correspond 
to the C-terminal globular domain of tetrapod PrPs on the basis of recently published 
comparisons of fish and tetrapod PrP sequences [8, 12, 13, 18]. The N-terminus was 
defined at residue Val-298, which is in a hydrophobic segment that has high sequence 
homology to tetrapod PrPs. The C-terminus could not be identified unambiguously, since 
the sequence after the predicted α-helix 3 has no homology to non-fish PrPs. The GPI 
cleavage site could be either at Asn-424 or Ser-430 [28]. As no regular secondary 
structure was predicted for the region between residues 424 and 430, we decided to place 
the C-terminal end at residue Arg-423. In the remainder of this paper, the polypeptide 
fragment of residues 298−423 is referred to as tr1-PrP. 
 
Expression and purification of tr1-PrP 
The His-tagged protein was expressed and purified from inclusion bodies, using the same 
method [4, 24] that had been successfully applied to obtain protein samples for three-
dimensional NMR structure determinations of a series of recombinant PrPs from 
mammals, birds, reptiles and amphibians [5, 7, 29]. Although the far-UV CD spectrum of 
tr1-PrP indicated the presence of some regular secondary structure, the 1H-NMR spectrum 
revealed only small peak dispersion (data not shown), showing that the protein does not 
exhibit a globular fold and thus indicating possible improper refolding of the protein from 
the inclusion bodies. In additional experiments, the constructs Fugu-
PrP1(298−450)[C426S] and Fugu-PrP1(355−450)[C426S], where Cys-426 was replaced 
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by serine, were tested for their folding properties. Fugu-PrP1(298−450)[C426S] was found 
to have a high tendency to aggregate during purification, whereas the behavior of Fugu-
PrP1(355−450)[C426S] was similar to the one of tr1-PrP. 
We next used an alternative expression strain with tr1-PrP, E. coli Origami BL21(DE3), 
which allows expression of proteins in oxidized soluble form in the cytoplasm of E. coli, 
and further enables variation of the IPTG concentration used to induce protein expression. 
In addition, chaperone systems such as Trigger Factor, GroEL/GroES and 
DnaJ/DnaK/GrpE were co-expressed to assist proper folding of the protein. Co-expression 
of Trigger Factor was found to yield the highest expression rate of soluble tr1-PrP and the 
lowest amount of co-purifying protein impurities (figure 2), whereas more impurities were 
observed with the GroEL/GroES system, and with the DnaJ/DnaK/GrpE system no 
expression of soluble tr1-PrP was obtained.  
In small-scale experiments, the concentrations of the inductors arabinose and IPTG, the 
temperature and the expression time were adjusted so as to maximize the yield of soluble 
protein. In the final protocol, induction of chaperone pre-expression with 2 g (L)-(+)-
arabinose per liter medium for 1 hour, a final IPTG concentration of 1 mM, an expression 
temperature of 25°C and an expression time of 15 hours were used (figure 2). 
Soluble tr1-PrP was isolated from the cells by sonication and centrifugation in a buffer that 
does not contain any detergents or denaturants (see Experimental procedures). The 
protein was purified by Nickel-affinity chromatography, using a stepwise imidazole gradient 
to remove two co-purifying proteins that could be identified by Edman-Sequencing, MS 
and a database search as the ribosomal protein S15 and the ferric uptake regulation 
protein from E. coli (Swiss-Prot accession numbers P0ADZ4 and Q0TK00, respectively). 
With this protocol, 1.8 mg of soluble oxidized tr1-PrP was obtained per liter of bacterial 
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culture in rich medium, and in minimal medium, using 15N-ammonium chloride as the sole 
nitrogen source, the yield was 0.4 mg per liter. 
 
Characterization of tr1-PrP with CD and NMR spectroscopy 
To compare the conformation of tr1-PrP with that of recombinant mammalian prion 
proteins, we used CD and NMR spectroscopy. In the far-UV CD spectra, there are 
indications that tr1-PrP and mPrP(121−231) both contain α-helical secondary structure, 
but the mean residue ellipticity of tr1-PrP is approximately one third less negative as the 
one of mPrP(121–231), indicating a lower content of residues located in regular secondary 
structure elements (figure 3). 
In additional CD experiments, the thermal denaturation and the urea-induced unfolding 
transitions of tr1-PrP and mPrP(121−231) were compared (figure 4, A and B). Thermal 
denaturation and urea-induced unfolding of mPrP(121−231) is highly cooperative, as 
previously reported [30, 31], whereas tr1-PrP unfolds in a less-cooperative manner typical 
for proteins that have no compact globular fold. 
NMR spectroscopy provided further evidence that no conformationally homogeneous 
sample of tr1-PrP was obtained in our experiments. The presence of peaks with variable 
line shape and intensity in the 2D [15N,1H]-HSQC spectrum indicates that the protein is 
prone to aggregation (figure 5A). The absence of a globular fold is supported by the small 
dispersion of the amide proton chemical shifts (figure 5, A and B). In a 2D [1H,1H]-NOESY 
spectrum, the region expected to contain NOE-peaks between methyl groups and 
aromatic rings in globular proteins is empty for tr1-PrP (figure 5B).
 
 - 10 - 
Conclusions 
Our presently reported investigations indicate that the gene coding for tr1-PrP, which has 
been annotated as the fish gene corresponding to prnp in mammals [11, 12], does not 
encode a protein that can be isolated and purified with the biochemical methods used for 
other PrPs. This might be due to the fact that the identification of fish prnp genes was 
based on the coincidence with characteristic features that had previously been identified in 
bona fide PrPs, i.e., the N-terminal signal sequence, the Gly−Pro-rich region, the 
hydrophobic region and the presence of two cysteine residues, two glycosylation sites and 
the putative C-terminal GPI-anchor site (figure 1). The overall sequence homology of the 
globular C-terminal domain with different tetrapod PrPs is actually only between 15−25% 
[11, 12]. Furthermore, the sequence identity is largely concentrated in the segment 
114−154 (numeration according to mPrP), which covers a hydrophobic stretch preceding 
the globular domain, and the regular secondary structures β1 and α1 (figure 1). In the 
remaining part of the putative globular domain with helices α2 and α3, the homology is 
essentially limited to the alignment of the two Cys residues (figure 1). 
 
On grounds of principle, one cannot a priori exclude that alternative constructs with 
variable lengths would lead to a folded protein, especially since previous studies with 
mammalian PrPs showed that deletions at the N-terminal as well as the C-terminal end of 
the globular domain resulted in destabilization of the three-dimensional structures ([32], 
unpublished data). However, since the N-terminal part of the presently studied fish prion 
protein constructs includes the highly homologous hydrophobic stretch (figure 1), which is 
unstructured in bona fide prion proteins, it seems unlikely that N-terminal elongation would 
result in a folded protein. The C-terminal end of the presently used tr1-PrP construct was 
chosen at the proposed GPI-anchor site, and an alternative construct including the natural 
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stop-codon (tr1-PrP(298−450)[C426S]) yielded no folded protein either. It thus appears 
that the absence of a globular domain cannot be rationalized by inappropriate truncation of 
the tr1-PrP constructs used. 
Overall, we conclude from our data that the Fugu-PrP1 gene annotated as corresponding 
to bona fide prnp genes in all non-fish species studied so far, does not encode a protein 
that forms a typical prion protein three-dimensional structure when isolated with the same 
purification and refolding methods that were successful with the other species. 
Considering that the sequence homology among fish species is 60% within PrP1s, 50% 
within PrP2s, and 40% between PrP1s and PrP2s [8], one is tempted to hypothesize that 
all fish PrPs might behave differently from tetrapod PrPs.  
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Experimental procedures 
Cloning of the proteins 
The plasmid containing the genes for Zebrafish PrP1, PrP2 and for Fugu-PrP1 were kindly 
provided by Dr. E. Málaga-Trillo (University of Konstanz, Germany). All protein fragments 
were cloned into the vector pRSET-A (Invitrogen, Carlsbad, CA, USA), which contains an 
N-terminal hexa-histidine tag (6 x His) and a thrombin cleavage site [4]. 
 
Expression, purification and refolding of tr1-PrP from inclusion bodies 
Recombinant tr1-PrP was expressed, purified and refolded from inclusion bodies without 
removing the 6 x His tag, as described by Zahn et al. [4, 24]. 
 
Expression and purification of soluble tr1-PrP 
Tr1-PrP was expressed in E. coli Origami B cells (Novagen, Darmstadt, Germany), which 
have the ability to form disulfide bonds in the cytoplasma and allow variation of the IPTG 
concentration used to induce protein expression. Cells containing two plasmids, one 
coding for a co-expressing chaperone protein (Takara Bio Inc., Otsu, Japan) and one for 
the expression of recombinant tr1-PrP, were grown at 37°C either in rich medium or in 
minimal medium containing 15NH4Cl (1 g/l) as the sole nitrogen source under selective 
conditions (ampicillin 100 mg/l, kanamycin sulfate 15 mg/l, chloramphenicol 35 mg/l, 
tetracycline 12.5 mg/l). At an OD600 of 0.6, L-(+)-arabinose (1–4 g/l) was added to induce 
chaperone expression for 1–4 hours before the expression of tr1-PrP was induced by 
addition of IPTG. To optimize the expression yield, various temperatures in the range 
20−30°C and IPTG concentrations in the range 10 µM to 1 mM were tested. 
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In the final expression protocol, pre-expression of the chaperone proteins was carried out 
for 1 hour at 25°C, with an arabinose concentration of 2 g/liter, and after addition of 1 mM 
IPTG, both proteins were expressed for 15 hours. 
After cell harvesting, the protein was resuspended in 100 ml buffer A (100 mM sodium 
phosphate, 5 mM Tris/HCl, 10 mM imidazole, 0.1 mg/ml lysozyme, 1 mg DNAse, pH = 
8.0), sonicated for 30 minutes and centrifuged (19'000 rpm, 4°C, 1 hour). The supernatant 
was added to 20 ml of nickel-nitrilotriacetic acid (NTA) agarose resin (Qiagen, Valencia, 
CA, USA) and stirred for 1 hour. The agarose was first washed with buffer B (100 mM 
sodium phosphate buffer, 5 mM Tris/HCl, 10 mM imidazole, pH = 8.0) before the protein 
was eluted by a stepwise imidazole gradient of 50 mM, 150 mM and 500 mM imidazole in 
buffer C (100 mM sodium phosphate buffer, 5 mM Tris/HCl, pH = 8.0). Fractions 
containing tr1-PrP were pooled and dialyzed against 10 mM sodium acetate buffer at pH 
4.5, using a Spectrapor membrane (Rancho Dominguez, CA, USA) with MWCO 3500, and 
concentrated. The N-terminus of the protein was analyzed by Edman sequencing, and its 
mass was verified by ESI (calculated mass: 16'701.5 Da, measured mass: 16'701.8 Da). 
The Ellman assay showed absence of free thiols after unfolding, indicating that the purified 
tr1-PrP was completely oxidized [33]. Protein concentrations were measured by the 
absorbance at 280 nm, using a molar extinction coefficient of 20'590 M-1cm-1. 
 
CD spectroscopy 
All measurements were performed in 10 mM sodium acetate pH 4.5 on a Jasco J710 CD 
spectropolarimeter at 20°C. The sample of denatured tr1-PrP additionally contained 8 M 
urea. The CD spectra were recorded in 0.1 cm cuvettes at protein concentrations of 13−19 
µM. All spectra were corrected for the presence of the buffer. 
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Thermal unfolding transitions were monitored by following the mean residue ellipticity, 
[Θ]MRW, at 222 nm between 20 and 90°C at a constant heating rate of 1°C/min and protein 
concentrations of 27 µM tr1-PrP and 19 µM mPrP(121−231), respectively.  
To study the urea-induced unfolding transitions, the mean residue ellipticities at 222 nm 
were recorded in the presence of different urea concentrations at protein concentrations of 
22 µM for tr1-PrP and 33 µM for mPrP, respectively. The mean residue ellipticity was 
recorded for 30 s and averaged. The data for mPrP(121−231) were analyzed according to 




All measurements were performed at 20°C on Bruker DRX750 and Avance900 
spectrometers. The samples were measured in 10 mM [d4]-sodium acetate buffer at pH 
4.5, containing 90% H2O/10% D2O. The 2D [
1H,1H]-NOESY spectrum was recorded with a 
mixing time of 60 ms, using a 600 µM protein sample. 
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Figure Legends 
 
Figure 1: Amino acid sequence alignment of the putative fugu PrPs with mouse PrP. 
Mouse PrP [GenBank:NP_035300] (residues 108−254), Fugu-PrP1 [GenBank:AAN38988] 
(residues 286−450) and Fugu-PrP2 [GenBank:AAR99478] (residues 203−425) have been 
aligned using the EMBL ClustalW program (http://www.ebi.ac.uk/clustalw/). The residues 
in the box represent a pronouncedly hydrophobic region of the proteins. For the globular 
C-terminal domain of mouse PrP, the regular secondary structure elements are indicated 
above its sequence. Residues with a black background indicate identical amino acids in all 
three species, the ones in grey show the residues that are conserved in Fugu-PrP1 and 
PrP2.  
 
Figure 2: Expression and purification of tr1-PrP. 
A 16% Coomassie Blue-stained SDS-PAGE shows tr1-PrP (band at 16.7 kDa, marked 
with B) in the presence of the co-expressing chaperone trigger factor (band at 48 kDa, 
marked with A). Lane M: marker; lane 1: cell extract before arabinose induction; lane 2: 
cell extract 1 hour after arabinose-induction (2 g/liter culture); lane 3: cell extract after 
IPTG-induction (final concentration 1 mM) and protein expression for 15 hours; lane 4: 
purified tr1-PrP. 
 
Figure 3: Comparison of the CD-spectra of tr1-PrP and mPrP(121−231). 
The spectra of native (solid line) and urea-denatured (dotted line) tr1-PrP, and of 
mPrP(121–231) (broken line) were measured at pH 4.5. [Θ]MRW is the mean residue 
ellipticity in deg/cm2/dmol. 
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Figure 4: Thermal denaturation and chemical unfolding of tr1-PrP and 
mPrP(121−231). 
Thermal (A) and urea-induced unfolding (B) of tr1-PrP (•) and mPrP(121–231) (o) were 
monitored by the mean residue ellipticity at 222 nm. For this comparison, the previously 
reported unfolding curves for mPrP(121−231) [30] have been re-measured at identical 
conditions to those for tr1-PrP. The pH-value was 4.5, and the urea-denaturation was 
pursued at 20°C. For mPrP(121−231), continuous lines represent a fit of the data 
according to a two-state transition. [Θ]MRW is the mean residue ellipticity in deg/cm2/dmol. 
 
Figure 5: NMR-experiments with tr1-PrP. 
(A) 2D [15N,1H]-HSQC spectrum of the uniformly 15N-labeled protein. (B) 2D [1H,1H]-
NOESY spectrum of unlabeled tr1-PrP. The box in (B) marks the region where NOEs 
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Christen et al, Figure 5 
 
 
 
 
 
 
 
